Search
for
Sort by
Research 481–510 of 878
- Alopecia areata
- Cancer-Related Alopecia: From Etiologies to Global Management
- Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment
- Differentiation of frontal fibrosing alopecia and Lichen planopilaris on trichoscopy: A comprehensive review
- Impact of a topical lotion, CG428, on permanent chemotherapy-induced alopecia in breast cancer survivors: a pilot randomized double-blind controlled clinical trial (VOLUME RCT)
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- SALT score distribution with ritlecitinib treatment up to 24 months in alopecia areata
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- Alopecia Areata of the Nails: Diagnosis and Management
- Janus kinase inhibitors for alopecia areata: A narrative review
- Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer
- Association of resilience and perceived stress in patients with alopecia areata: A cross-sectional study
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Perceived Stigma and Mental Health Disorders Among Adults With Alopecia Areata Living in Japan
- Correlation between increased total serum IgE levels and clinical features in alopecia areata patients
- Assessment of Alopecia Areata Disease Severity in Pediatric Patients
- Patient preferences in the treatment of alopecia areata: A review of the literature
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- A new era for alopecia areata: New treatments and improved knowledge of the condition
- Frontal Fibrosing Alopecia and Reproductive Health: Assessing the Role of Sex Hormones in Disease Development
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2
- Janus Kinase inhibitors in dermatology: a review
- Content validity of five single‐item instruments in adolescents with alopecia areata
- Forging the Future: 2018 Alopecia Areata Research Summit Summary Report